Owen Hughes

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencecorroborated
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

Seats held as a director, as published in the cited sources.

1. 2026 to end not published
   Executive title: Chief Executive OfficerOrganization not published
   E2E3E1
2. 2026 to end not published
   Executive title: Chief Executive Officer (PEO)Organization not published
   E4

No education, credentials, or certifications are published in this record.

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
• Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
• Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
• Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Each relationship is one Claim rendered on every record it connects.

• CT
  C4 Therapeutics, Inc.Director, 2023 to present
  person:owen-hughes:role:1
• XR
  XOMA Royalty CorpDirector, 2023 to present
  person:owen-hughes:role:2
• I
  ImageneBio, Inc.Director, 2022 to present
  person:owen-hughes:role:3
• ON
  Organization not publishedExecutive title: Chief Executive Officer, 2026 to end not published; Executive title: Chief Executive Officer (PEO), 2026 to end not published
  person:owen-hughes:executive_title:12, person:owen-hughes:executive_title:13

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis

Public role at an organization in the published Registry

Sources

12 evidence records cited. 0 with redistribution rights.

Never published

Home address, family, personal contacts, health, and history unrelated to the public role

Profile claimed

No

Open disputes

0

Identity ownership

unclaimed

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

1. E1
   XOMAP DEF 14A executive officers

   SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved Jul 28, 2026. Cited by 5 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
2. E2
   XOMA DEF 14A director slate

   SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved May 16, 2026. Cited by 7 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   XOMA DEF 14A executive officers

   SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved Jul 11, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   XOMAO DEF 14A executive officers

   SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved Jul 28, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   Source title not published

   sec proxy. Published Mar 30, 2026. Retrieved Apr 25, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   CCCC DEF 14A director slate

   SEC EDGAR. sec filing. Published Apr 29, 2025. Retrieved May 15, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
7. E7
   Source title not published

   sec proxy. Published Apr 29, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
8. E8
   IMA DEF 14A director slate

   SEC EDGAR. sec filing. Published Apr 26, 2024. Retrieved May 16, 2026. Cited by 2 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
9. E9
   Source title not published

   sec proxy. Published Apr 26, 2024. Retrieved Apr 29, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
10. E10
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
11. E11
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
12. E12
    Source title not published

    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

• Owen Hughes seat on C4 Therapeutics, Inc., effective 2023-01-01.
• Director at XOMA Royalty Corp, effective 2023-01-01.
• Owen Hughes seat on ImageneBio, Inc., effective 2022-01-01.